Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 39 3-Year ROIIC % is -30.32 as of Dec. 2025. GuruFocus rates BJSE:920656 with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks worse than 72.22% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -30.32%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % or its related term are showing as below:
BJSE:920656's 3-Year ROIIC % is ranked worse than 72.22% of 18
companies
in the Healthcare Plans industry
Industry Median: -11.815
vs BJSE:920656: -30.32
Zhejiang Chemsyn Pharm Co (BJSE:920656) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Zhejiang Chemsyn Pharm Co 3-Year ROIIC % Related Terms
Zhejiang Chemsyn Pharm Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: 3-Year ROIIC % Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co 3-Year ROIIC % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a 3-Year ROIIC % of -30.32 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #13 out of 18 companies in the Healthcare Plans industry, placing it in the top 72.2%.
Is Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % too high?
Zhejiang Chemsyn Pharm Co's current 3-Year ROIIC % is -30.32. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #13 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's 3-Year ROIIC % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #13 out of 18 companies for 3-Year ROIIC %. This places Zhejiang Chemsyn Pharm Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Plans company?
A good 3-Year ROIIC % depends on the Healthcare Plans industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. Zhejiang Chemsyn Pharm Co's current 3-Year ROIIC % is -30.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current 3-Year ROIIC % of -30.32. The current 3-Year ROIIC % is -30.32. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current 3-Year ROIIC % is -30.32 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
39GF Score
Get the complete analysis for BJSE:920656
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
